Temple Biotic 30ct

$55.00
By Tummy Temple

Temple Biotic is a high potency, shelf stable, dairy-free, friendly bacteria repopulator. This new formulation contains 50 billion CFU per capsule and is formulated without inulin or other fermentable carbohydrates, making it suitable for carbohydrate-sensitive individuals or those adhering to restricted diets such as GAPS and FODMAP. Temple Biotic consists of ten of the most highly researched probiotic strains, with each strain and specific CFU count being fully disclosed. These are robust strains that are capable of surviving the harsh journey to the intestines and are able to attach to the intestinal walls, where they can grow and function effectively to support GI health. The survivability of the strains is further assisted by delayed release technology as well as unique moisture-resistant, desiccant-lined packaging. This novel packaging removes the need for refrigeration, making Temple Biotic convenient for travelers and anyone on the go.*

Temple Biotic is ideal for the following:

  • Daily maintenance
  • Concurrent or post antibiotic support
  • Immune support and balancing
  • Maintaining a healthy intestinal microbiome

Serving Size: 1 vegetable capsule (50 billion CFU)

Servings Per Container: 30

Recommended Use: As a dietary supplement, take one capsule per day with a meal, or as directed by your health care practitioner.

GLUTEN FREEDAIRY FREESOY FREEVEGETARIANNON-GMOVEGAN

Highlights:

  • Combines 10 boutique strains at therapeutically significant dosages

  • Evidence‐based formulations using researched and validated strains

  • Specific strain identification with disclosed colony‐forming unit (CFU) count

  • Significant overage ensures long shelf life and guarantees delivery of stated CFU count

  • State‐of‐the‐art moisture, oxygen, and light‐resistant, desiccant‐lined packaging to protect probiotics and extend shelf life, and to eliminate the need for refrigeration

  • Superior tolerance and resistance to stomach acid and bile salts

  • Capsules featuring delayed‐release technology for optimal survivability from stomach acid and properly timed release of the probiotics in the lower GI tract

  • Strong adherence to intestinal epithelial and mucosal walls

  • Does not cause antibiotic resistance

  • Dairy‐free formulations


  1. Ingredient Highlights

    Lactobacillus acidophilus (DDS®‐1) is a potent immunomodulatory probiotic strain shown to promote immune activity by increasing regulatory T cells, inducing chemokine and cytokine response, stimulating dendritic cells to promote T helper type (Th)1/Th2/Th3 immunity, and improving immunoglobulin (Ig)A response. It also supports butyrate and other short‐chain fatty acid (SCFA) production, downregulates inflammatory cytokines, supports the abundance of other beneficial bacteria, and enables immune maturation in fetal enterocytes. Additionally, studies have found it to have superior survival and adhesion rates.1‐7

    L. acidophilis has also been shown to improve microbiome diversity after antibiotic therapy. Studies demonstrate that
    L. acidophilus DDS®‐1 alone or as part of a probiotic combination significantly improves colitis and abdominal pain, normalizes bowel movements in irritable bowel syndrome (IBS), improves abdominal symptoms of lactose intolerance, improves atopic dermatitis in children, supports faster improvement in functional constipation, shortens acute respiratory infections in children, reduces incidence and duration of cold and flu symptoms, and moderates the effects of anticipatory stress due to night shift work.7‐19

    Lactobacillus plantarum (UALp‐05TM) significantly inhibits the invasion of pathogenic E. coli, especially when combined with other probiotic strains, and it effectively reduces disturbance of the microbiome resulting from antibiotic therapy.19,20


This information is provided as a medical and scientific educational resource for the use of physicians and other licensed health‐care practitioners ("Practitioners"). This information is intended for Practitioners to use as a basis for determining whether to recommend these products to their patients. All recommendations regarding protocols, dosing, prescribing, and/or usage instructions should be tailored to the individual needs of the patient considering their medical history and concomitant therapies. This information is not intended for use by consumers.

Benefits*

  • High‐potency maintenance for healthy microbiota balance

  • Supports a healthy immune response

  • Supports normal bowel movements

  • Supports a healthy GI system

  • Supports recovery from antibiotic treatment

Ingredient Highlights: 

Studies show it reduces abdominal pain, bloating, and other GI symptoms associated with IBS and colitis.21,22 It has also been shown to have good resistance in the digestive tract, along with adhesion and immunomodulatory effects, including upregulating anti‐inflammatory interleukin (IL)‐10 and downregulating IL‐8 cytokine production.4 As an immunomodulatory agent, L. plantarum enhances the IgG response and improves the body’s response to influenza, especially in elderly.23,24

Bifidobacterium lactis (UABla‐12TM) has been present in human food for decades and is broadly recognized for its key role in the human intestinal microflora throughout life. Its anti‐inflammatory properties are useful in attenuating the symptoms of colitis and supporting the body against allergies and allergic rhinitis.22,25 It protects and restores the microbiome after antibiotic therapy and boosts the body’s IgG response.11,25 It has been found to support colitis, atopic dermatitis, acute respiratory infections in children, the stress associated with night shifts, functional constipation, and IBS, especially in combination with L. acidophilus DDS®‐1.7,14‐18

Lactobacillus casei (UALc‐03TM) improves systemic and mucosal immune responses, reducing the occurrence of infections, especially in the elderly.26,27 Its anti‐inflammatory properties are noted, as it lowers high‐sensitivity C‐reactive protein (hsCRP), reduces the occurrence of necrotizing enterocolitis, modifies expression of the toll‐like receptor in ulcerative colitis, and repairs aspirin‐induced bowel injury.28‐31 L. casei may also help improve insulin sensitivity and support healthy glucose metabolism.32

Bifidobacterium breve (UABbr‐11TM) is a normal commensal microorganism that prevents and improves constipation, abdominal bloating, and anal itch, burn, and pain. It also helps to improve other symptoms of ulcerative colitis and necrotizing enterocolitis.31,33,34 It may also support healthy fasting glucose and hsCRP while increasing plasma glutathione.35

Lactobacillus paracasei (UALpc‐04TM) can inhibit pathogenic salmonella, S. aureus, E. coli, and listeria while protecting and restoring the microbiome after antibiotic therapy.11 As an immunomodulatory agent, it induces IL‐10, tumor necrosis factor‐alpha (TNF‐α), interferon‐γ, and IL‐12, and it enhances the IgG and IgM responses.23 Studies have found that the immunomodulating properties may support atopic dermatitis and peripheral immune responses in celiac disease.36,37Colitis models show a significant reduction in intestinal inflammation with L. paracasei therapy.38,39 It has also been shown to benefit IBS.40

Lactobacillus salivarius (UALs‐07TM) mitigates inflammatory symptoms and modulates cytokine production and the cellular response to pathogenic challenges while restoring a disrupted microbiome.11,41 It also improves oral health by reducing gum bleeding and physiologic halitosis while increasing resistance to dental caries.42,43

Lactobacillus rhamnosus (GG) is a potent immunomodulatory strain that increases interleukin and cytokine production, inhibits TNF‐α, phagocytosis and natural killer cell activity, IgA secretion, and inhibits the production of lipopolysaccharides (LPS) or endotoxins. It also supports fetal immunity and imparts some of the immunomodulatory components of breast milk. L. rhamnosus produces a beneficial biofilm that can protect the mucosa to support intestinal epithelial integrity.44 Studies have found L. rhamnosus to be beneficial for IBD and diarrhea, especially in children, acute gastroenteritis in children, functional GI disorders, antibiotic‐associated diarrhea, allergies, IBS, and upper respiratory infections in children.44‐50

Bifidobacterium bifidum (UABb‐10TM) improves functional constipation and symptoms of IBS, including abdominal pain, bloating, belching, flatulence, and diarrhea. The improvement in functional constipation was also observed when used in combination with L. acidophilus DDS‐1®, B. lactis UABla12TM, and B. longum UAB1‐14TM.7 Upper GI symptoms associated with H. pylori infections also benefit from B. bifidum.51

Bifidobacterium longum (UABI‐14TM) improves the composition and metabolic activities of colonic bacterial communities and immune parameters, helping the symptomatic effects of celiac disease, IBS, and functional constipation.52,53 Studies show B. longum significantly reduces TNF‐α, C‐reactive protein, serum aspartate aminotransferase, insulin resistance, serum endotoxin, and steatosis in patients with nonalcoholic steatohepatitis.54 The improvement in functional constipation was also observed when used in combination with L. acidophilus DDS‐1®, B. lactis UABla12TM, and B. bifidum UABb‐10TM.7

    *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent disease.

    View details